Business & FinanceTop StoryTop StoryLatest News
Venomics AI Raises $2.7 Million to Discover Drugs from Animal Venom
Sentiment: NeutralHigh Priority
What Happened?
Venomics AI, a biotech firm from the Indian Institute of Science, has secured $2.7 million in its first funding round. The investment will enhance its drug discovery platform utilizing animal venom.
Key points
- Venomics AI raised $2.7 million in a pre-seed funding round.
- The funding was co-led by Speciale Invest and South Park Commons.
- The investment will support the expansion of the Venom Atlas dataset.
- Venomics AI aims to explore the molecular diversity of animal venoms.
- The company combines AI with experimental screening for drug discovery.
- Kartik Sunagar and Vinay Prabhu co-founded Venomics AI.
Key insights
- The integration of AI in drug discovery could accelerate the identification of therapeutic candidates.
- India's rich biodiversity offers a unique advantage for discovering new medicines.
- The collaboration of experts in venom biology and AI may lead to significant medical breakthroughs.
Why it matters
This funding could enhance drug discovery efforts using animal venoms, potentially leading to new therapeutics.
Tags
Entities
Venomics AI· CompanyIndian Institute of Science· OrganizationSpeciale Invest· OrganizationSouth Park Commons· OrganizationKartik Sunagar· PersonVinay Prabhu· Person
Source
Business Standard
